This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (32)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA

Takeshi Usami, MD; Katsushi Koyama, MD; Oki Takeuchi, MD; Kunio Morozumi, MD; Genjiro Kimura, MD

JAMA. 2000;284:2622-2624.

Context  Despite recent medical advances, the number of patients beginning dialysis annually is increasing in both the United States and Japan. The ethnically homogeneous population of Japan presents an opportunity to study the presence of factors other than race/ethnicity that might contribute to incidence of end-stage renal disease (ESRD).

Objective  To determine if and where regional differences exist in ESRD in Japan.

Design, Setting, and Subjects  Analysis of data reported by the Japanese Society for Dialysis Therapy based on the annual number of patients with ESRD beginning maintenance dialysis therapy in all 47 prefectures of Japan from 1982 to 1998.

Main Outcome Measures  Mean annual ESRD incidence and increasing rate of ESRD in each of 11 predefined areas making up the entire country.

Results  Incidence of ESRD increased approximately 3-fold in Japan during the study years, from 81.3 per 1 million in 1982 to 237.6 per 1 million in 1998. Significant regional differences were found in both measures. The mean (SEM) annual ESRD incidence (P<.01) and increasing rate of ESRD (P<.01), respectively, were significantly different across Japan. Koshinetsu (140 [11] per 1 million and 9.1 [0.6] per 1 million/y) and Hokuriku (141 [12] per 1 million and 9.7 [0.5] per 1 million/y) were the areas with the lowest incidence and increasing rate of incidence, while Okinawa (188 [17] per 1 million and 13.4 [0.6] per 1 million/y) and Kyushu (179 [15] per 1 million and 12.0 [0.6] per 1 million/y) were the areas with the highest incidence and increasing rate of incidence.

Conclusions  We found definite and significant regional differences in incidence and increasing rate of incidence of ESRD in Japan. Further analyses are needed to identify factors that contribute to these regional differences and thereby improve strategies for treatment of renal disease.

Author Affiliations: Department of Internal Medicine and Pathophysiology, Nagoya City University Medical School, Nagoya, Japan.

RELATED ARTICLE

November 22/29, 2000
JAMA. 2000;284(20):2657-2658.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Integrated therapies including erythropoietin decrease the incidence of dialysis: lessons from mapping the incidence of end-stage renal disease in Japan
Furumatsu et al.
Nephrol Dial Transplant 2008;23:984-990.
ABSTRACT | FULL TEXT  

Renin Angiotensin Aldosterone System Blockade and Renal Disease in Patients With Type 2 Diabetes: An Asian perspective from the RENAAL study
Chan et al.
Diabetes Care 2004;27:874-879.
ABSTRACT | FULL TEXT  

Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-1999
Stengel et al.
Nephrol Dial Transplant 2003;18:1824-1833.
ABSTRACT | FULL TEXT  

Regional variability in the incidence of end-stage renal disease: an epidemiological approach
Wimmer et al.
Nephrol Dial Transplant 2003;18:1562-1567.
ABSTRACT | FULL TEXT  

Regional variability in the incidence of end-stage renal disease: an epidemiological approach
Wimmer et al.
Nephrol Dial Transplant 2003;18:1562-1567.
ABSTRACT | FULL TEXT  

The Okinawa Screening Program
Iseki
J. Am. Soc. Nephrol. 2003;14:S127-130.
ABSTRACT | FULL TEXT